A lack of raw materials used in the manufacture of Pfizer’s COVID-19 vaccine played a role in the company’s decision to slash its 2020 production target, a spokeswoman told Reuters.
Lack of raw materials blamed for slashed supply target of Pfizer’s COVID-19 vaccine
